-
Filterlex Medical raises $3M in Series A Financing
biospectrumasia
July 16, 2019
Filterlex won the best innovation award at the EuroPCR 2019 conference in Paris and was awarded $200,000 prize by the Jon DeHaan Foundation
-
New analysis shows that 3,400 drug prices have risen in 2019 so far
europeanpharmaceuticalreview
July 04, 2019
The price of over 3400 drugs have been hiked in the first half of 2019, surpassing the number of hikes imposed during the same period last year.
-
New opioid-alternative raises $3.25 million for Phase I trials
firstwordpharma
January 13, 2019
AmacaThera, a Toronto-based company commercializing hydrogel-based drug delivery platforms, has already raised $3.25 million (CAD) in seed financing from Sprout BioVentures, Viva Biotech, and Grey Sky Venture Partners and welcomes additional investors.
-
New opioid-alternative raises $3.25 million for Phase I trials
firstwordpharma
January 13, 2019
AmacaThera, a Toronto-based company commercializing hydrogel-based drug delivery platforms, has already raised $3.25 million (CAD) in seed financing from Sprout BioVentures, Viva Biotech, and Grey Sky Venture Partners and welcomes additional investors.
-
Aptamer Group: UK Biotech Business Raises $2.2M Investment
b3cnewswire
July 24, 2018
Rapidly growing biotech business, Aptamer Group Ltd, has closed its Series A investment round after attracting international interest, securing $2.2m of funding from overseas investors to support its pioneering aptamer development programme.